Pablo de la Torre

627 citations
29 papers · 422 indexed · h-index 10

Pablo de la Torre

26 papers receiving 401 citations

Peers

Pablo de la Torre
Comparison fields: 5 of 55
  • Urology 67
  • Pulmonary and Respiratory Medicine 305
  • Rheumatology 122
  • Transplantation 15
  • Obstetrics and Gynecology 34
Replace Roberto Peschechera with:
Roberto Peschechera Italy
Ari Adamy United States
Kamol Panumatrassamee Thailand
Osamu Matsuura Japan
S.M. Moudouni France
Marie Audouin France
P Carretero Spain
Rolf Gillitzer Germany
N. Bissada United States
Joanne Nyarangi‐Dix Germany
Pablo de la Torre relative to Roberto Peschechera Italy Roberto Peschechera's profile →
Citations per field
00.5×1.5×
Roberto Peschechera · 1×
Citations per year

Countries citing papers authored by Pablo de la Torre

Since Specialization
Citations

This map shows the geographic impact of Pablo de la Torre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo de la Torre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo de la Torre more than expected).

Fields of papers citing papers by Pablo de la Torre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo de la Torre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo de la Torre. The network helps show where Pablo de la Torre may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pablo de la Torre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pablo de la Torre Line = papers co-authored together Pablo de la Torre links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 20161
3 20156
4 201526
5 20148
6 20131
7 20121
8 201015
9 200927
10 20085
11 20070
12 20051
13 20056
14 200517
15 200545
16 200115
17 200171
18 20016
19 20002
20 199963

About Pablo de la Torre

Pablo de la Torre is a scholar working on Transplantation, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 29 papers that have together received 422 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Renal and Vascular Pathologies (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers), MRI in cancer diagnosis (4 papers), Renal cell carcinoma treatment (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Ureteral procedures and complications (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Urology (67 citations), Pulmonary and Respiratory Medicine (305 citations) and Rheumatology (122 citations). Pablo de la Torre has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Samir S. Taneja, Gurdip S. Sidhu, Juan Palou, Herbert Lepor, Gary K. Lefkowitz, José M. Corberán, Argimiro Collado, J. Vicente, H. Villavicencio and Anna Bujons. Their work appears in journals such as The Journal of Urology, Radiographics and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026